DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for sebocystomatosis — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSebocystomatosis maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for sebocystomatosis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Diseases of the Colon & Rectum · 1966 · 3 citations
Adenomatosis of the colon associated with sebaceous cysts, osteomas, and fibrous tumors
AbstractSummary A case of adenomatosis of the colon accompanied by sebocystomatosis is presented. The existence of a definite syndrome characterized by the presence of sebaceous cysts, osteomas, or fibrous tumors, or combinations of these in conjunction with adenomatosis, is acknowledged. Its importance in detection of undiagnosed cases of adenomatosis is obvious. Divergent opinions regarding the extent of resection advisable for these patients are mentioned.
AbstractSebocystomatosis, a rare skin disease characterized by sebum-filled skin cysts, affected a 28-year-old female. Lesions started at 12 years, initially located on the sternum, then extending to the forearms and abdomen. A biopsy confirmed the diagnosis of sebocystomatosis, revealing epidermal cysts in the dermis with sebaceous glands. Sebocystomatosis is sparsely documented in medical literature. Our patient presents persistent skin lesions, diagnosed as sebocystomatosis by biopsy. Early recognition is crucial for management, emphasizing the importance of biopsy for the accurate diagnosis of this skin disease.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
